Corteva, Inc. (NYSE:CTVA) Receives $91.50 Consensus PT from Analysts

Shares of Corteva, Inc. (NYSE:CTVA) have earned an average recommendation of “Moderate Buy” from the twenty-three analysts that are covering the company, MarketBeat.com reports. Nine investment analysts have rated the stock with a hold recommendation and fourteen have given a buy recommendation to the company. The average twelve-month target price among brokers that have issued a report on the stock in the last year is $91.50.

Several equities research analysts recently commented on the stock. Mizuho boosted their price target on shares of Corteva from $96.00 to $97.00 and gave the stock an “outperform” rating in a report on Tuesday, July 14th. Royal Bank Of Canada increased their price objective on shares of Corteva from $97.00 to $103.00 and gave the company an “outperform” rating in a report on Tuesday, July 21st. Citigroup lifted their target price on shares of Corteva from $85.00 to $86.00 and gave the company a “neutral” rating in a research report on Monday, August 3rd. Jefferies Financial Group boosted their target price on shares of Corteva from $95.00 to $97.00 in a research note on Thursday, May 7th. Finally, JPMorgan Chase & Co. upped their price target on shares of Corteva from $77.00 to $83.00 and gave the stock a “neutral” rating in a research report on Monday, August 3rd.

Corteva Stock Performance

Shares of CTVA stock opened at $82.27 on Tuesday. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.07. Corteva has a 12-month low of $60.53 and a 12-month high of $90.97. The business’s 50 day moving average is $82.58 and its two-hundred day moving average is $80.52. The company has a market capitalization of $54.89 billion, a P/E ratio of 54.48, a P/E/G ratio of 2.54 and a beta of 0.57.

Corteva (NYSE:CTVA) last posted its quarterly earnings data on Thursday, July 30th. The company reported $2.30 EPS for the quarter, beating analysts’ consensus estimates of $2.24 by $0.06. Corteva had a return on equity of 10.18% and a net margin of 5.66%.The business had revenue of $6.38 billion during the quarter, compared to analysts’ expectations of $6.60 billion. During the same period in the previous year, the business earned $2.20 earnings per share. The business’s revenue was down 1.2% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. Analysts expect that Corteva will post 3.72 EPS for the current fiscal year.

Corteva Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 15th. Shareholders of record on Tuesday, September 1st will be paid a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a yield of 0.9%. The ex-dividend date is Tuesday, September 1st. Corteva’s payout ratio is 47.68%.

Hedge Funds Weigh In On Corteva

Several hedge funds and other institutional investors have recently made changes to their positions in the company. California State Teachers Retirement System raised its stake in Corteva by 7,664.4% in the 2nd quarter. California State Teachers Retirement System now owns 139,830,304 shares of the company’s stock valued at $11,842,228,000 after purchasing an additional 138,029,377 shares during the last quarter. Vanguard Group Inc. grew its holdings in shares of Corteva by 0.4% during the fourth quarter. Vanguard Group Inc. now owns 80,536,951 shares of the company’s stock worth $5,398,392,000 after buying an additional 317,538 shares in the last quarter. BlackRock Inc. purchased a new stake in shares of Corteva during the second quarter worth $4,560,180,000. State Street Corp raised its position in shares of Corteva by 3.7% in the fourth quarter. State Street Corp now owns 36,570,876 shares of the company’s stock valued at $2,451,346,000 after buying an additional 1,290,071 shares during the last quarter. Finally, Franklin Resources Inc. raised its position in shares of Corteva by 4.3% in the fourth quarter. Franklin Resources Inc. now owns 19,537,500 shares of the company’s stock valued at $1,309,599,000 after buying an additional 805,873 shares during the last quarter. Hedge funds and other institutional investors own 81.54% of the company’s stock.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid?2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.